DCGI Gives Green Signal To Oxford COVID Vaccine’s Human Trials In India
New Delhi: The Drugs Controller General of India (DCGI) has given green signal to Pune-based Serum Institute of India (SII) to conduct the phase 2 and 3 of clinical human trials of the University of Oxford-developed COVID-19 vaccine in…